Sangamo Therapeutics
SGMO
$0.52
Share price
2.94%
Change (1 day)
-67.84%
Change (1 year)
Sangamo Therapeutics (SGMO) - Cash on Hand
Cash on Hand as of December 2023 : $81 M
According to Sangamo Therapeutics
's latest financial reports the company has $81 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Sangamo Therapeutics - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $81 M | -70.82% |
| 2022-12-31 | $0.27 B | -26.27% |
| 2021-12-31 | $0.37 B | -41.29% |
| 2020-12-31 | $0.64 B | 76.96% |
| 2019-12-31 | $0.36 B | -9.41% |
| 2018-12-31 | $0.40 B | 64.46% |
| 2017-12-31 | $0.24 B | 70.7% |
| 2016-12-31 | $0.14 B | -31.8% |
| 2015-12-31 | $0.20 B | 16.78% |
| 2014-12-31 | $0.17 B | 92.82% |
| 2013-12-31 | $92.81 M | 46.05% |
| 2012-12-31 | $63.54 M | -24.47% |
| 2011-12-31 | $84.13 M | 39.56% |
| 2010-12-31 | $60.28 M | -29.03% |
| 2009-12-31 | $84.94 M | 31.02% |
| 2008-12-31 | $64.83 M | -20.05% |
| 2007-12-31 | $81.08 M | 50.39% |
| 2006-12-31 | $53.92 M | 14.83% |
| 2005-12-31 | $46.95 M | 41.18% |
| 2004-12-31 | $33.26 M | -24.16% |
| 2003-12-31 | $43.85 M | -15.89% |
| 2002-12-31 | $52.14 M | -15.34% |
| 2001-12-31 | $61.59 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.92 B | 28,204.24% | 🇺🇸 USA |
 Amgen AMGN | $10.94 B | 13,410.78% | 🇺🇸 USA |
 Biogen BIIB | $1.04 B | 1,196.14% | 🇺🇸 USA |
 Dow DOW | $2.98 B | 3,587.56% | 🇺🇸 USA |
 Gilead Sciences GILD | $7.26 B | 8,867.68% | 🇺🇸 USA |
 Merck MRK | $7.09 B | 8,656.57% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $2.43 B | 2,911.51% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $1.07 B | 1,225.66% | 🇺🇸 USA |